INMD - InMode - Stock Price & Dividends

InMode Ltd. is a pioneer in the medical aesthetics industry, dedicated to designing, developing, manufacturing, and marketing innovative, minimally invasive products that transform the way aesthetic procedures are performed.

The company's proprietary technologies, including radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency, enable medical professionals to offer a range of treatments, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation. These cutting-edge solutions also address various women's health conditions and procedures.

In addition to its minimally invasive offerings, InMode Ltd. also develops and markets non-invasive medical aesthetic products that cater to a broad spectrum of procedures. These include permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture improvement, and the treatment of superficial benign vascular and pigmented lesions.

The company's innovative approach extends to its hands-free medical aesthetic products, which target a range of procedures, including skin tightening, fat reduction, and muscle stimulation. This comprehensive portfolio of products enables medical professionals to provide their patients with a wide range of treatment options, ultimately enhancing their overall aesthetic experience.

With a rich history dating back to 2008, InMode Ltd. (formerly known as Invasix Ltd.) has established itself as a leader in the medical aesthetics industry. Headquartered in Yokne'am, Israel, the company continues to push the boundaries of innovation, providing medical professionals with the tools they need to deliver exceptional results and improve patient outcomes.

For more information about InMode Ltd. and its innovative products, please visit their website at https://www.inmodemd.com.